Medical error

Summit Venture Studio Licenses Medication Administration Protection System to Enhance Medication Safety

Retrieved on: 
Tuesday, March 19, 2024
Medicine, PMID, Risk, EMR, Patient, Internet, Pharming, Research, Artificial intelligence, Software, Death, HMH, Medical error, Patient safety, Machine learning, LEHI, MAPS, Health, Approximation error, BMJ, Nursing

LEHI, Utah, March 19, 2024 /PRNewswire-PRWeb/ -- Summit Venture Studio is excited to announce its license and commercialization of the clinical surveillance tool MAPS (Medication Administration Protection System). MAPS is a pioneering software, designed by Houston Methodist, that enhances medication safety in the health care setting.

Key Points: 
  • Summit Venture Studio is excited to announce its license and commercialization of the clinical surveillance tool MAPS (Medication Administration Protection System).
  • MAPS is a pioneering software, designed by Houston Methodist, that enhances medication safety in the health care setting.
  • LEHI, Utah, March 19, 2024 /PRNewswire-PRWeb/ -- Summit Venture Studio is excited to announce its license and commercialization of the clinical surveillance tool MAPS (Medication Administration Protection System).
  • MAPS is a pioneering software, designed by Houston Methodist, that enhances medication safety in the health care setting.

Imprivata launches new Biometric Patient Identity solution to protect patient privacy and address misidentification crisis

Retrieved on: 
Tuesday, February 27, 2024
Cloud, Name, Epic Systems, Medicine, Fraud, EHR, Approximation error, Communication, Risk, Identity theft, Health care, HIPAA, City, Medical error, Allergy, Organization, Patient, Privacy, Facial recognition, Research, Nursing

WALTHAM, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Imprivata , the digital identity company for life- and mission-critical industries, today announced the availability of Imprivata Biometric Patient Identity , a first-of-its-kind facial recognition solution developed for the unique privacy needs of healthcare organizations to ensure accurate and efficient patient identification.

Key Points: 
  • WALTHAM, Mass., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Imprivata , the digital identity company for life- and mission-critical industries, today announced the availability of Imprivata Biometric Patient Identity , a first-of-its-kind facial recognition solution developed for the unique privacy needs of healthcare organizations to ensure accurate and efficient patient identification.
  • The solution comes at a critical time when patient misidentification presents a growing problem in the U.S., as research shows that 24% of an organization’s healthcare records were duplicates.
  • Designed with HIPAA compliance in mind, the solution solely uses biometric data for approved purposes, ensuring patient data stays as private as the patient’s health record.
  • Imprivata invites healthcare professionals and organizations to discover more about Imprivata Biometric Patient Identity and embrace the future of patient safety with confidence.

Challenges with home-use medical devices for patients and caregivers tops ECRI's 2024 health tech hazards

Retrieved on: 
Wednesday, January 31, 2024
ECRI, Electrode, Nursing, MD, Caregiver, Patient, Safety, Patient safety, Fatality, Artificial intelligence, Pump, Risk, Medical error, Doctor of Philosophy, Organization, Hospital, Medical device

PLYMOUTH MEETING, Pa., Jan. 31, 2024 /PRNewswire/ -- One of the nation's largest nonprofit patient safety organizations has named challenges for patients and caregivers using medical devices at home as the most pressing health technology safety hazard for 2024. Reflecting industry trends, the list also includes multiple concerns related to artificial intelligence (AI) and data security.

Key Points: 
  • ECRI is a nonprofit patient safety organization and the only independent evaluator of medical technology and devices.
  • ECRI follows a rigorous review process to select topics, drawing insight from incident investigations, reporting databases, and independent medical device testing.
  • As a result, medical devices such as infusion pumps and ventilators are now being used in the home, sometimes by caregivers and patients who have not been sufficiently trained.
  • In ranked order, ECRI's Top 10 Health Technology Hazards for 2024 are:
    Now in its 17th year, ECRI's Top 10 Health Technology Hazards report identifies critical healthcare technology issues.

Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert® Xpress MVP

Retrieved on: 
Thursday, January 18, 2024
Cepheid variable, MVP, Woman, Yeast, Patient, Vaginitis, Infection, Trichomonas, CLIA, Diagnosis, Bacterial vaginosis, Risk, Recurrence, BV, Medical error, VVC, Candidiasis, PCR, EVP, Physician, Pharmaceutical industry

SUNNYVALE, Calif., Jan. 18, 2024 /PRNewswire/ -- Cepheid announced today that it has received FDA Clearance with Clinical Laboratory Improvement Amendments (CLIA) waiver for Xpert® Xpress MVP. This multiplex vaginal panel can now be performed in near-patient settings, enabling results within 60 minutes from a single specimen for Bacterial Vaginosis (BV), Vulvovaginal Candidiasis (VVC), and Trichomoniasis (TV). This expanded claim exemplifies Cepheid's commitment to providing expanded access to women's and sexual health by making PCR testing accessible at the point of care. The test runs on Cepheid's GeneXpert Xpress instruments and has been approved for testing women fourteen years of age and older.

Key Points: 
  • SUNNYVALE, Calif., Jan. 18, 2024 /PRNewswire/ -- Cepheid announced today that it has received FDA Clearance with Clinical Laboratory Improvement Amendments (CLIA) waiver for Xpert® Xpress MVP.
  • This expanded claim exemplifies Cepheid's commitment to providing expanded access to women's and sexual health by making PCR testing accessible at the point of care.
  • The test runs on Cepheid's GeneXpert Xpress instruments and has been approved for testing women fourteen years of age and older.
  • For more information about Cepheid's Xpert Xpress MVP test, please visit Cepheid's website.

A Safer Tomorrow: AESOP Technology's Battle Against Look-Alike, Sound-Alike Medication Errors

Retrieved on: 
Monday, October 23, 2023
Name, Documentation, Medical error, Hope, Physician, Approximation error, AESOP, AI, Patient, Patient safety, SAN, Fatigue, Nursing, Medical device

SAN FRANCISCO, Oct. 23, 2023 /PRNewswire/ -- Medication errors are a critical problem in healthcare, and Look-Alike, Sound-Alike (LASA) medication errors pose a particularly daunting challenge.

Key Points: 
  • SAN FRANCISCO, Oct. 23, 2023 /PRNewswire/ -- Medication errors are a critical problem in healthcare, and Look-Alike, Sound-Alike (LASA) medication errors pose a particularly daunting challenge.
  • Studies show that LASA errors account for approximately one in four medication errors, making them a significant threat to patients.
  • AESOP Technology is thus pleased to announce remarkable results from its recent clinical research , demonstrating its exceptional effectiveness in preventing LASA errors.
  • More than half of all medication errors occur during the prescription phase, making it a critical focus for improving patient safety.

The Kryder Law Group, LLC Highlights Alarming Trend in Medical Malpractice Payouts in Illinois

Retrieved on: 
Thursday, October 12, 2023
Disease, Medical error, Patient, Statistics, Personal injury, National Practitioner Data Bank, Failure, Diagnosis

CHICAGO, Oct. 12, 2023 /PRNewswire/ -- The Kryder Law Group, LLC, a personal injury and medical malpractice law firm, has uncovered alarming statistics from the National Practitioner Data Bank (NPDB) regarding medical malpractice payouts in Illinois.

Key Points: 
  • CHICAGO, Oct. 12, 2023 /PRNewswire/ -- The Kryder Law Group, LLC, a personal injury and medical malpractice law firm, has uncovered alarming statistics from the National Practitioner Data Bank (NPDB) regarding medical malpractice payouts in Illinois.
  • Analyzing data over a ten-year period from 2013 to 2022, the firm found that about 50% of medical malpractice payments in Illinois, almost 1,400 cases, were made because of a failure to correctly execute a medical procedure, the failure to diagnose a disease or condition, improper management of a patient, or a delay in diagnosis.
  • They also noted that the highest medical malpractice payouts in Illinois ranged from ~$5.2 million to ~$22.5 million with just 23 cases accounting for about $250 million in medical negligence payouts.
  • "These numbers highlight the need for patients to understand their rights and seek legal advice when things go wrong," said Andrew S. Kryder, founding partner at The Kryder Law Group, LLC.

I-PASS Institute Earns MedPro Group Endorsement

Retrieved on: 
Tuesday, September 26, 2023
General Health, Hospitals, Health, Medicine, Communication, Partnership, Hospital, Risk management, MedPro Group, Journal, MD, Patient safety, Death, Medical error, Medical device, Nursing

I-PASS , the gold standard for reducing communication-related medical errors for healthcare providers nationwide, today announced that it has been endorsed by MedPro Group as a trusted patient safety and risk management solution.

Key Points: 
  • I-PASS , the gold standard for reducing communication-related medical errors for healthcare providers nationwide, today announced that it has been endorsed by MedPro Group as a trusted patient safety and risk management solution.
  • The I-PASS handoff bundle is a proven, sustainable solution for minimizing patient harm and improving care transition communication.
  • MedPro Group is the nation’s leading malpractice carrier, offering their network of more than 300,000 healthcare providers customized insurance, claims, patient safety, and risk management services and solutions.
  • The endorsement signifies a shared commitment between MedPro Group and I-PASS to reduce communication-related adverse events that contribute to patient harms.

Optavise Partners with SentryHealth to Help Employees Become Better Informed About Their Healthcare with Enhanced Clinical Advocacy and Virtual Care Solution

Retrieved on: 
Thursday, August 24, 2023
Workforce, Learning, Partnership, Education, Health, CNO, CNO Financial Group, Medical error, Diagnosis, Nursing

This partnership provides employers with an end-to-end solution to support employees in understanding, navigating and managing their benefits and healthcare.

Key Points: 
  • This partnership provides employers with an end-to-end solution to support employees in understanding, navigating and managing their benefits and healthcare.
  • Clinical advocacy offers dedicated professionals who will provide education on a diagnosis and discuss treatment plan options, both of which are crucial additions to Optavise's current advocacy services .
  • Now, with Optavise's integrated clinical advocacy and virtual care solutions provided by SentryHealth, employers can offer high-touch concierge services that help employees better understand, navigate and manage their health and wellbeing.
  • "The cost of healthcare continues to rise for employers and employees alike," said J. Kevin Porter, President & CEO, SentryHealth.

KINDRA SHINES LIGHT ON MENOPAUSE MISDIAGNOSIS CRISIS

Retrieved on: 
Thursday, August 10, 2023
Chief Medical Advisor to the President, Arm, Education, Aetna, Sleep, Menopause, Woman, Statistics, Incontinence, FACOG, Doctor of Philosophy, LMFT, Mindfulness, Pelvic floor, Prolapse, Human, Patient, Medical error, Cedars-Sinai Medical Center, Health, MPH, Mental health, Birth control, Health insurance, MD

NEW YORK, Aug. 10, 2023 /PRNewswire/ -- With nearly 1 in 3 women of menopausal age (age 45-54) having received a menopause misdiagnosis, sex-positive and vaginal health brand Kindra has recognized the urgent need for broader medical access in menopause care. Today, Kindra announces the appointments of their expert medical advisory board, led by Dr. Suzanne Gilberg-Lenz, MD, FACOG, and Dr. Seema Shah, MD, MPH, FACOG, as well as collaborative educational work with Dr. Juliana Hauser, PhD, LMFT. Kindra is also announcing partnerships with leading menopause healthcare providers Gennev and Origin with the goal of closing the care gap. 

Key Points: 
  • Kindra is also announcing partnerships with leading menopause healthcare providers Gennev and Origin with the goal of closing the care gap.
  • According to a recent Harris poll, the statistics on menopause care are staggering:
    "Misdiagnosis is far too common, and while the conversation on menopause is getting louder everyday, the care of our vaginas is still woefully underfunded," said Catherine Balsam-Schwaber, CEO Founder of KINDRA.
  • Dr. Seema Shah, MD is a board-certified Obstetrician and Gynecological Surgeon, leading hospital system menopause expert, and public health champion.
  • "In menopause, the one thing we know for certain is that each of us has our own journey," stated Dr. Suzanne Gilberg Lenz, Kindra Senior Medical Advisor.

You might have heard ADHD risks being over-diagnosed. Here's why that's not the case

Retrieved on: 
Wednesday, June 28, 2023
Diabetes, Anxiety, ADHD, Cancer, National Disability Insurance Scheme, Overdiagnosis, Approximation error, Attention, Medicine, Attention deficit hyperactivity disorder predominantly inattentive, Attention deficit hyperactivity disorder, Work, Time, Spectrum, Medical error, Diagnosis, NDIS, Death, Family, GP, Psychiatric-mental health nurse practitioner, Disease, Dietary supplement, Health insurance, Mobile phone, Medical imaging, Medical device, Nursing

One hot topic is whether ADHD is being over-diagnosed.

Key Points: 
  • One hot topic is whether ADHD is being over-diagnosed.
  • Public hearings for the Australian Senate’s inquiry into “consistent, timely and best practice assessment” of ADHD and support services begin today.

What is ADHD?

    • Worldwide, around 5% of children and 2.5% of adults meet the full diagnostic criteria for ADHD.
    • Importantly, just having hyperactive, impulsive and inattentive symptoms is not sufficient to qualify for a diagnosis of ADHD.
    • To meet current diagnostic criteria, these symptoms must have a negative effect on a person’s “social, school, or work functioning”.

Overdiagnosis or misdiagnosis?

    • Overdiagnosis is a concept first developed in cancer screening to highlight situations where “the diagnosis of disease that would never cause symptoms or death during a given patient’s lifetime”.
    • This definition has since been employed in many other areas of medicine, as well as analyses of health systems.
    • When defined in this way, overdiagnosis is distinct from the concept of misdiagnosis, which is where an incorrect diagnosis has been made.

Different definitions

    • One 2021 article on ADHD and overdiagnosis defined it as occurring when the “net effect of the diagnosis is unfavourable”.
    • There are many reasons an ADHD diagnosis may be “unfavourable”, for some individuals.
    • Some people experience negative side effects from ADHD treatments, or experience stigma as a result of ADHD diagnosis.
    • But when you think about ADHD as not just having certain symptoms, but as having harmful outcomes, this might be expected.

Not a medical condition

    • Some concerns about ADHD overdiagnosis appear to be based on a belief ADHD should not be considered as a medical condition.
    • From this perspective, the concerns would again be more accurately and transparently phrased in terms of misdiagnosis.
    • Even in the United States where rates of ADHD diagnosis exceed 5%, they still fall short of the estimated epidemiological prevalence.

Where to from here?

    • So GPs and others – like Mental Health Nurse Practitioners – may well play an important role in assessing and managing ADHD.
    • There would clearly need to be extensive training and support and also changes in the way assessments are funded.
    • He also receives funding from the Medical Research Future Fund David Coghill receives funding from The National Health & Medical Research Council and the Medical Research Future Fund.